1. Home
  2. TELA vs VNRX Comparison

TELA vs VNRX Comparison

Compare TELA & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
  • VNRX
  • Stock Information
  • Founded
  • TELA 2012
  • VNRX N/A
  • Country
  • TELA United States
  • VNRX United States
  • Employees
  • TELA 209
  • VNRX N/A
  • Industry
  • TELA Medical/Dental Instruments
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • TELA Health Care
  • VNRX Health Care
  • Exchange
  • TELA Nasdaq
  • VNRX Nasdaq
  • Market Cap
  • TELA 62.6M
  • VNRX 64.8M
  • IPO Year
  • TELA 2019
  • VNRX N/A
  • Fundamental
  • Price
  • TELA $1.51
  • VNRX $0.62
  • Analyst Decision
  • TELA Buy
  • VNRX Strong Buy
  • Analyst Count
  • TELA 3
  • VNRX 4
  • Target Price
  • TELA $5.33
  • VNRX $3.50
  • AVG Volume (30 Days)
  • TELA 74.6K
  • VNRX 192.3K
  • Earning Date
  • TELA 11-06-2025
  • VNRX 11-13-2025
  • Dividend Yield
  • TELA N/A
  • VNRX N/A
  • EPS Growth
  • TELA N/A
  • VNRX N/A
  • EPS
  • TELA N/A
  • VNRX N/A
  • Revenue
  • TELA $75,323,000.00
  • VNRX $1,319,252.00
  • Revenue This Year
  • TELA $25.72
  • VNRX $399.39
  • Revenue Next Year
  • TELA $22.03
  • VNRX $242.09
  • P/E Ratio
  • TELA N/A
  • VNRX N/A
  • Revenue Growth
  • TELA 16.34
  • VNRX 35.10
  • 52 Week Low
  • TELA $0.86
  • VNRX $0.40
  • 52 Week High
  • TELA $3.26
  • VNRX $0.94
  • Technical
  • Relative Strength Index (RSI)
  • TELA 37.37
  • VNRX 44.73
  • Support Level
  • TELA $1.53
  • VNRX $0.57
  • Resistance Level
  • TELA $1.73
  • VNRX $0.73
  • Average True Range (ATR)
  • TELA 0.15
  • VNRX 0.05
  • MACD
  • TELA -0.01
  • VNRX -0.00
  • Stochastic Oscillator
  • TELA 0.00
  • VNRX 31.25

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: